ライフサイエンスコーパス: interquartile

1 D], +/-0.50 D, +/-0.75 D, and +/-1.00 D; and interquartile displays) and statistical methods of analy

2 58+/-10 years) followed up for a median 4.7 (interquartile interval, 4.0-5.7) years, low-attenuation

3 ons occurred a median of 138 times per case [interquartile range (IQR) 96-190].

4 The odds ratio (OR) per interquartile range (IQR) increase [9,200 particles per

5 imated covariate-adjusted associations of an interquartile range (IQR) increase in log(2)-transformed

6 inter-site MAP variability was 6mmHg with an interquartile range (IQR) of 3 to 9 mmHg.

7 90 women were followed for a median of 24.2 (interquartile range (IQR), 14.2-34.5) months, correspond

8 of voltage was observed (bipolar: 38 cm(2) [interquartile range (IQR), 25-54] versus 53 cm(2) [IQR,

9 le (77% men); age at admission was 47 years [interquartile range (IQR), 40-53 years], age of onset of

10 herosclerosis progression (median: 1 plaque [interquartile range (IQR): -1 to 3 plaques] by 2DVUS; 7.

11 ed in an area under the curve (AUC) of 0.80 (interquartile range (IQR): 0.73-0.86) for discriminating

12 iltration coefficient was lower (calf: 3.30 [interquartile range (IQR): 2.33 to 3.88] l x 100 ml of t

13 infants, median gestational age 26.9 weeks [interquartile range (IQR): 26.3-28.4], median birth weig

14 ine arsenic:creatinine ratio was 7.54 mug/g [interquartile range (IQR): 4.90-11.93] and the cadmium:c

15 ubjects had low hepatic triglycerides (0.5% [interquartile range 0.1%-0.5%]), in contrast to lipodyst

16 , median intracerebral hemorrhage score 1.5 [interquartile range 1-2], delirium prevalence 57% [n = 3

17 Their median CHA(2)DS(2)-VASc score was 2 (interquartile range 1-3).

18 Studies used a median of 2 instruments (interquartile range 1-4 instruments) and evaluated a med

19 After a median follow-up time of 696 days (interquartile range 1201 d), survival was significantly

20 Median follow-up was 18 d (interquartile range 13, 30).

21 time to the next exacerbation was 32.5 days (interquartile range 13-50) in the placebo arm and 34 day

22 range 13-50) in the placebo arm and 34 days (interquartile range 17-62) in the ciprofloxacin arm, whi

23 Median follow-up was 21 years (interquartile range 18-24 years).

24 tional Institutes of Health Stroke Scale 4, [interquartile range 2-11]) compared with VKA (6, [2-14])

25 uments) and evaluated a median of 2 domains (interquartile range 2-3 domains).

26 en the two paired assessments was 1.4 years (interquartile range 2.15 years).

27 Median time from transplant was 5.58 y (interquartile range 2.25, 7.33).

28 0.5%]), in contrast to lipodystrophy (10.6% [interquartile range 2.8%-17.1%], P < 0.0001).

29 7 patients (58% female; median age 34 years [interquartile range 28-41]) were ART-eligible at enrollm

30 ) were included (74% females, median age 36 [interquartile range 28-50] years).

31 terquartile range 3619) and women (7260 with interquartile range 3068; P=0.52).

32 The median central macular ChT was 370 mum (interquartile range 312-406 mum).

33 The median age of patients was 50 years (interquartile range 33-63) and 37% were female.

34 step count was similar among men (7202 with interquartile range 3619) and women (7260 with interquar

35 The median age of cases was 49.5 years (interquartile range 39-59).

36 evaluated using a median of 77 instruments (interquartile range 39-87 instruments).

37 ber of cases would have been 67-fold higher (interquartile range 44-94-fold) by 29 February 2020, and

38 ber of ICU beds needed at the peak by 48.4% (interquartile range 46.4-50.3%), although still exceedin

39 duals on 2DRs were older (median 52.6 years [interquartile range 46.7-59.0] vs 47.7 [39.7-54.3]), and

40 ed (from 22 sites); their median age was 56 (interquartile range 47-62).

41 rence after a median follow-up of 10 months (interquartile range 5-17).

42 Biobank (median age at enrollment 63 years, interquartile range 55-72; 38% female; recruitment 2008-

43 s (17,886, 51%, female; median age 71 years, interquartile range 57-82 years).

44 /2016), 284 children (median age 10.7 years, interquartile range 6.7-14.8) were recruited.

45 Median follow-up was 108 months, interquartile range 66-136.

46 Median time to IRIS was 11 days (interquartile range 7-40 days) after antiretroviral ther

47 f ICU beds is substantially higher at 73.5% (interquartile range 71.4-75.3%).

48 e were a total of 114,325 cases of COVID-19 (interquartile range 76,776-164,576) in mainland China as

49 The median LNR was 20% (interquartile range 9-40).

50 A total of 57 adults (median age 24 years [interquartile range = 20-29]), 53% of whom were female,

51 edian Eczema Area and Severity Index = 28.3; interquartile range = 25.2-35.3).

52 l second trimester alpha-T level was 63 muM (interquartile range = 47-82).

53 widely across DSAs, with a median of 15.1% (interquartile range [9.3%, 20.9%]; range 0.0%-32.0%).

54 ) with a median follow-up time of 5.9 years (interquartile range [IQR] 1.1-14.2).

55 Median age at first booking was 25 years (interquartile range [IQR] 21 to 30), and median parity w

56 CMV DNA (median plasma viral load 498 IU/mL, interquartile range [IQR] 259-2390).

57 age among included children was 4.7 months (interquartile range [IQR] 3-6), 49.5% were female, 23% h

58 ersion was significantly shorter (6.0 weeks, interquartile range [IQR] 4.0-8.3) in the moxifloxacin g

59 al surgery and orbital emphysema was 8 days (interquartile range [IQR] 5-15 days).

60 -OPs, with considerable OPO-level variation (interquartile range [IQR] 54.7%-75.3%; range 0%-100%).

61 equiring a median of 11 doses of eculizumab (interquartile range [IQR] 7-20).

62 cs decreased in the teleID group (median 15, interquartile range [IQR] 9-25), compared to the pre-tel

63 edicted with a median absolute error of 4.8 (interquartile range [IQR] = 1.3-12.8) at 1 week poststro

64 dian time between CT and MRI was 35 minutes (interquartile range [IQR] = 24-50).

65 The median age was 17.0 years (interquartile range [IQR] = 9.0-29.0 years; range = 0-80

66 The median 24-2 VF MD was -6.8 dB (interquartile range [IQR], -4.9 to -12.3 dB).

67 d at least 1 anti-VEGF treatment (median, 4; interquartile range [IQR], 0-12).

68 uration with Spo2 of less than 90%, was 0.7 (interquartile range [IQR], 0.1-5.1) minutes per hour amo

69 n) showed a median viral load of 0.54 cp/ml (interquartile range [IQR], 0.22 to 1.46 cp/ml) and a 14%

70 The median age was 2.8 years (interquartile range [IQR], 1.3 to 5.3); 8.5% (30/353) we

71 ets used for training (median age, 64 years; interquartile range [IQR], 11), 15 for validation (media

72 n CD4 count at diagnosis increased from 326 (interquartile range [IQR], 132-504) cells/uL to 390 (IQR

73 Rvol(FLOW) was higher (median, 24.8 mL; interquartile range [IQR], 14.3-45.7 mL) than Rvol(VALVE

74 eprivation than after normal sleep: (30 min [interquartile range [IQR], 17-41] vs. 60 min [IQR, 45-60

75 harge to last recorded follow-up of 30 days (interquartile range [IQR], 17-46 days).

76 group, median filter life span was 47 hours (interquartile range [IQR], 19-70 hours) vs 26 hours (IQR

77 ative score categories (1+ to 4+) were 1:10 (interquartile range [IQR], 1:5 to 1:20) in the CrAgSQ 1+

78 The median age of patients was 53 years (interquartile range [IQR], 33-69 years) and 100 (48.3%)

79 ived among patients on bedaquiline-based (4; interquartile range [IQR], 4-4) and delamanid-based (4;

80 The median baseline VA was 60 (interquartile range [IQR], 45-70) letters, which improve

81 Diabetic Retinopathy Study (ETDRS) letters (interquartile range [IQR], 5.0-20.0) from 65.0 (IQR, 58.

82 The median age was 60 years old (interquartile range [IQR], 54, 66), and 23% were African

83 with DM (both groups: median age, 59 years; interquartile range [IQR], 54-64 years).

84 tively, over median follow-up of 15.5 years (interquartile range [IQR], 6.3 years) and 14.2 (IQR, 2.5

85 at presentation of 35 children was 26 days (interquartile range [IQR], 7-106 days).

86 verall, patients were followed for a median (interquartile range [IQR], range) of 49.5 (15.3, 7.0-66.

87 stomach, kidneys, and bone marrow were 0.88 (interquartile range [IQR]: 0.85-1.04), 0.42 (IQR: 0.25-1

88 alized in 62 patients (75%) within 3 months (interquartile range [IQR]: 1.5 to 6 months) of anticoagu

89 nducted in 1,023 patients-very early, 2.5 h (interquartile range [IQR]: 1.8 to 4.2 h), n = 583; and s

90 nderwent TPVR at a median age of 18.3 years (interquartile range [IQR]: 12.9 to 27.3 years) and weigh

91 ary veins [PVs]; mean ablation time: 22 min; interquartile range [IQR]: 15 to 29 min) and LAPW ablati

92 dialysis facilities in Network 6 was 33.7% (interquartile range [IQR]: 25.3%-43.1%).

93 were males; median procedure times were 50 (interquartile range [IQR]: 38-71) and 60(IQR: 48-77) min

94 end-stage liver disease score at LT was 7 ((interquartile range [IQR]: 6-11) and waiting time 78.5 d

95 notyped cohort of 893 PCOS cases (median and interquartile range [IQR]: age = 28 [25-32], body mass i

96 Length of stay was reported as median and interquartile range for laparoscopic and robotic: 1.0 da

97 recipients (n = 26) above the upper limit of interquartile range for weight gain at 1 year.

98 r the same averaging window of 21 days, each interquartile range increase in daily PM(2.5) was associ

99 lutant model of particle radioactivity, each interquartile range increase in particle radioactivity f

100 ds of a VA event (95% CI, 15%-90%), and each interquartile range increase of particle radioactivity w

101 ED visits for influenza were associated with interquartile range increases in concentrations of GAS (

102 For example, interquartile range increases in PNC within the size ran

103 edian follow-up time was 7.4 months, with an interquartile range of 3.3 to 13.1 months (standard devi

104 rmalized to the whole lung mean (FV(N)), and interquartile range of normalized ventilation (IQR(N); a

105 linical presentations (median Pitt score, 0 [interquartile range {IQR} 0-1] vs 1 [IQR 0-2] in patient

106 d significantly lower median h-indices (4.0 [interquartile range {IQR} 7.0] vs 11.0 [IQR 17.0], P < .

107 -low group than the sero-high group (9 days [interquartile range {IQR} 7.5-11.0] vs 11.0 days [IQR 7.

108 in younger children (median age, 1.7 years [interquartile range {IQR}, 0.1-6.9]) compared with immun

109 isolates was similar to that of NL4.3 (1.01 [interquartile range {IQR}, 0.86 to 1.18]), while the med

110 FeNO than uninfected controls (median, 17.0 [interquartile range {IQR}, 11.0-26.0] vs 13.0 [IQR, 9.0-

111 cohort, 162 patients [median age, 29 years; interquartile range {IQR}, 24-36 years; 84 men]) were us

112 Fifty-eight children (median age, 9 years [interquartile range {IQR}, 5.7-14]; 20 girls [34%]) were

113 9 (99%) completed the trial (median age, 66 [interquartile range {IQR}, 56-74] years; 246 [36%] women

114 ngth of stay was shorter (control: 30 hours [interquartile range {IQR}, 6-122] vs diversion: 22 [IQR,

115 Of the 203 participants (median age, 68 [interquartile range {IQR}, 65-71] years; median type 1 d

116 Fluid overload % increased from median (interquartile range) 1.58% (0.23-3.56%; n = 1,017) on da

117 ity kidneys (median Kidney Donor Risk Index (interquartile range) 1.9 (1.0) vs 1.2 (0.7)), there was

118 Among these 69 cases, the median (interquartile range) age was 24 (4.5-196) months, 42 wer

119 The median age (interquartile range) at IPD due to serotypes 8 (59 [45-7

120 The median (interquartile range) duration of follow-up was 1.02 (0.3

121 5-196) months, 42 were male, and the median (interquartile range) duration of hospitalization was 8 (

122 During a median (interquartile range) follow-up of 6.8 (2.5-11.4) years,

123 The median (interquartile range) follow-up time was 4.6 (2.7-7.1) ye

124 The median (interquartile range) for international normalized ratio

125 54.3% women) were followed up for a median (interquartile range) of 8.9 (8.3-9.5) years.

126 The median (interquartile range) of APRI (n = 106), FIB-4 (n = 106),

127 perative days [area under the curve: median (interquartile range) pg/mL: 3285 (1697-6179) vs 1290 (75

128 t baseline of 76.60+/-6.65 years and median (interquartile range) review period of 1.17 years (1.01-1

129 Median (interquartile range) steady-state trough TFV concentrati

130 The median (interquartile range) time from KPD entry to transplantat

131 Median (interquartile range) TTR were 37.0 h (21.8 to 51.7 h) an

132 nterindividual variability and lower median (interquartile range) values for sTXB2 (ng/mL) compared w

133 uals, median most diseased segment TBR(max) (interquartile range) was higher in culprit than in noncu

134 PC vs no-CPC (area under the curve), median (interquartile range): 5196 (1823-9061) vs 1934 (831-5301

135 artile range, -536 to 153 mL] versus -14 mL [interquartile range, -282 to 335 mL]; P=0.035) and plasm

136 35 mL]; P=0.035) and plasma volume (-138 mL, interquartile range, -379 to 154+/-453 mL; P=0.04).

137 ing in a reduction in blood volume (-208 mL [interquartile range, -536 to 153 mL] versus -14 mL [inte

138 ntage of time in atrial fibrillation was 0% (interquartile range, 0 to 0.08) with ablation and 0.13%

139 e range, 0 to 0.08) with ablation and 0.13% (interquartile range, 0 to 1.60) with antiarrhythmic drug

140 s (interquartile range, 5 to 78) and 1 hour (interquartile range, 0 to 17), respectively (absolute di

141 utes post-emergency department presentation (interquartile range, 0-109 min), with 83.1% meeting Sequ

142 range, 1-3) than the 4-mm scans (median, 1; interquartile range, 0-3; P = 0.008).

143 The RS had a median value of 0.08 (interquartile range, 0.007-0.71) and a weak and modest c

144 ly lower IgE binding (median ELISA OD, 0.03; interquartile range, 0.01-0.06) than natural Ara h 2 (me

145 During a median follow-up of 0.4 (interquartile range, 0.1-1.4) years, there were 42 (8%)

146 rformed at a median PSA value of 0.60 ng/mL (interquartile range, 0.3-2.4) after a median of 6 mo (in

147 Median PSA was 1.2 ng/mL (interquartile range, 0.6-2.8 ng/mL).

148 etastatic disease at a median of 5.9 months (interquartile range, 0.8-28 months).

149 The median ICU length of stay was 1.57 days (interquartile range, 0.82-2.97 d).

150 than natural Ara h 2 (median ELISA OD, 0.99; interquartile range, 0.90-1.03; P < .01).

151 t delirium with a median duration of 2 days (interquartile range, 1-3 d).

152 days [interquartile range, 2-6 d] vs 2 days [interquartile range, 1-3 d]; p = 0.04).

153 tected on the 2-mm scans (median, 2 lesions; interquartile range, 1-3) than the 4-mm scans (median, 1

154 n, with median time to recovery of 2 months (interquartile range, 1-3), whereas 16 (6.0%) died.

155 luenza-positive hospitalizations was 2 days (interquartile range, 1-4), 18% (95% confidence interval

156 During 2.3 years (interquartile range, 1.0-4.3) follow-up, 160 patients ex

157 days [interquartile range, 4-7 d] vs 3 days [interquartile range, 1.5-5 d]; p < 0.001) and increased

158 The median age at enrollment was 3.2 months (interquartile range, 1.7-5.8 months).

159 ed <=17 years with a median age of 19 years (interquartile range, 10-32); 423 (52.9%) were males.

160 itive with median ART duration of 41 months (interquartile range, 10-84 months).

161 s [interquartile range, 5 to 7] vs. 13 days [interquartile range, 11 to 14]; absolute difference, 7 d

162 exceeding 96%, with a duration of 27 hours (interquartile range, 11 to 63.5) and 49 hours (interquar

163 ere selected, with a median weight of 18 kg (interquartile range, 11-32).

164 3.0-39.7] uSv in no drape group versus 15.3 [interquartile range, 11.1-20.0] uSv in the drape group;

165 ain Results: The median MPP deficit was 19% (interquartile range, 13-25), and 54% (interquartile rang

166 A median of 39% (interquartile range, 14-72%) of patients had directives

167 Over a median follow-up of 24.5 (interquartile range, 14.8-33.4) months, 52 deaths and 24

168 ata from 782 patients (median age, 59 years [interquartile range, 15 years]) from 54 health care site

169 3 [interquartile range, 221-795] versus 325 [interquartile range, 154-698]; P=0.014).

170 The median number of excised nodes was 21 (interquartile range, 16-27).

171 of spontaneous circulation was 21.1 minutes (interquartile range, 16.1-26.9), and median duration of

172 tibiotic exposure was 41% of inpatient-days (interquartile range, 16.7%-62.5%).

173 ge, 7.6-22.0) and HFOV at the highest (25.7; interquartile range, 16.7-37.3).

174 The median age was 36 months (interquartile range, 18-60): 15% were aged between 1-11

175 s 19% (interquartile range, 13-25), and 54% (interquartile range, 19-82) of time points were spent wi

176 ian number of ingested substances was three (interquartile range, 2-4); 51.5% were single-substance e

177 asive mechanical ventilation (median 4 days [interquartile range, 2-6 d] vs 2 days [interquartile ran

178 intensity on the numeric rating scale was 4 (interquartile range, 2-6) in the week before survey resp

179 lmonary resuscitation duration was 3.2 days (interquartile range, 2.1-4.9 d).

180 Baseline aBSI (median, 4.5; interquartile range, 2.4-6.5) was moderately correlated

181 recipients at 1 year posttransplant was 10% (interquartile range, 2.7%-19.3%) of baseline weight.

182 nd during the median follow-up of 6.1 years (interquartile range, 2.7-11), 9,776 (4.2%) patients were

183 ring follow-up (median follow-up, 3.1 years; interquartile range, 2.7-3.4 years; range, 0.2-3.8 years

184 erapy patients (median follow-up, 4.2 years [interquartile range, 2.7-6.1]) were analyzed.

185 22 to 27) in the surgery group and 22 years (interquartile range, 21 to 27) in the control group; dat

186 terquartile range, 11 to 63.5) and 49 hours (interquartile range, 22 to 112), respectively (absolute

187 ion of follow-up for mortality was 24 years (interquartile range, 22 to 27) in the surgery group and

188 ere enrolled; the median age of HHCs was 33 (interquartile range, 22-49) years, and 62% were women.

189 0 persons (51% female; median age, 43 years [interquartile range, 22-62 years]) at the time of the pr

190 reference to directives in a median of 24% (interquartile range, 22-70%).

191 h a median cohort size of 4161 participants (interquartile range, 2204 to 8634 participants).

192 her in black than in nonblack patients (403 [interquartile range, 221-795] versus 325 [interquartile

193 t inclusion criteria, the median Crs was 30 (interquartile range, 23-40) ml/cm H(2)O.

194 n operator radiation dose (median dose 30.5 [interquartile range, 23.0-39.7] uSv in no drape group ve

195 geted temperature management was 32.9 hours (interquartile range, 23.7-37.8).

196 (10.3) years, 34.4% female, median BMI 26.6 (interquartile range, 24.1-30.1), 46.6% had zero CAC, and

197 brane oxygenation support time was 96 hours (interquartile range, 26-181 hr).

198 During a median follow-up of 40.1 months (interquartile range, 26.5-50.7 months), patients with NA

199 d (51% female, median FEV(1%) predicted, 36 [interquartile range, 27-48]).

200 tissue culture infectious dose/mL was 1780 (interquartile range, 282-8511).

201 a median hospital length of stay of 7 days (interquartile range, 3 to 14 days), 533 patients (22%) w

202 ode to immunotherapy initiation was 5 years (interquartile range, 3-12 years).

203 y numbers for peak shedding were 1.99 x 107 (interquartile range, 3.39 x 106 to 6.37 x 107).

204 workers wearing one badge (median, 6.9 mSv; interquartile range, 3.8213.8 mSv; n = 6218) were simila

205 210 men (62%), with median age of 39 years (interquartile range, 31-45 years).

206 [interquartile range, 52.6-85.7] versus 41.1[interquartile range, 32.0-78.3]; P=0.047), whereas the d

207 42 patients (41%) after a median of 62 days (interquartile range, 33-123 days), a rate higher than th

208 ears (302 [54%] male) (median follow-up, 34 [interquartile range, 33.7-34.7] years).

209 e rate for newer P2Y12 inhibitors was 51.3% (interquartile range, 35.0%-65.9%), with substantial vari

210 The median gestational age was 39.1 weeks (interquartile range, 38.2-40 wk) and mortality in hospit

211 e frequently over time with a median of 58% (interquartile range, 39-89%).

212 rquartile range, 588-1563 days] vs 678 days [interquartile range, 392-916 days], respectively; P = .0

213 tile range, 0.3-2.4) after a median of 6 mo (interquartile range, 4-10) after RARP.

214 ntiretroviral therapy for PLHIV was 8 years (interquartile range, 4-10) and 96% were virally suppress

215 from diagnosis to enrollment was 23 months (interquartile range, 4-122), with a median of 3 prior th

216 ciated with longer PICU stay (median 5 days [interquartile range, 4-7 d] vs 3 days [interquartile ran

217 ars, with a median time to LT of 7.5 months [interquartile range, 4.4-10.3].

218 f staff wearing two badges (median, 7.1 mSv; interquartile range, 4.6-11.2 mSv; n = 1449) (P = .18),

219 vi [mean fluorescence intensity (MFI), 48.1; interquartile range, 41.7 to 59.6] to primary melanomas

220 ment criteria a median of 118 minutes later (interquartile range, 44-401 min).

221 luated were 156 women (median age, 50 years; interquartile range, 44-63 years).

222 ere enrolled, with a median age of 50 years (interquartile range, 45-55 years); 31% were female, 43%

223 le range, 49-66 years] for DCM and 55 years [interquartile range, 46-62 years] for nonamyloid RCM, P<

224 (duration of combined MCS: median 94 hours; interquartile range, 49-150 hours).

225 st 2013 to July 2015) (median age, 56 years; interquartile range, 49-66 years) and 762 by using DBT (

226 uartile range, 55-69 years] versus 58 years [interquartile range, 49-66 years] for DCM and 55 years [

227 e median door-to-needle time was 65 minutes (interquartile range, 49-88 minutes).

228 n group, with a median duration of 29 hours (interquartile range, 5 to 78) and 1 hour (interquartile

229 p than in the control group (median, 6 days [interquartile range, 5 to 7] vs. 13 days [interquartile

230 rval since the onset of symptoms was 7 days (interquartile range, 5 to 9).

231 ion before heart transplantation was 9 days (interquartile range, 5-15 d) and median follow-up post h

232 presenting an ACS after a median time of 12 (interquartile range, 5-17) months post-TAVR.

233 k 130 desensitization success was 6.2 years (interquartile range, 5.2-9.1) versus 9.4 years (interqua

234 rs), and the median follow-up was 7.6 years (interquartile range, 5.7-9.9; range, 0.2-19.2).

235 nterquartile range, 69-172 vs 77 procedures, interquartile range, 50-119 in the prior year; standardi

236 st 2015 to July 2017) (median age, 58 years; interquartile range, 50-67 years), (P = .58).

237 sas City Cardiomyopathy Questionnaire, 68.0 [interquartile range, 52.6-85.7] versus 41.1[interquartil

238 d available ICD codes (median age, 69 years [interquartile range, 54 to 81 years]) and 11.7% had an a

239 otal of 1070 patients (median age, 66 years; interquartile range, 54-75 years; 626 men) were included

240 2 randomized patients (median age, 60 years [interquartile range, 55-65 years]; 182 men [60.3%]), 283

241 tients with ACM (n=46) were older (61 years [interquartile range, 55-69 years] versus 58 years [inter

242 (25 men and 25 women; median age, 61 years [interquartile range, 56-69 years]; 40 with locally advan

243 were Black, and the median age was 66 years (interquartile range, 56-75 yr).

244 s The median age of the cohort was 64 years (interquartile range, 57-70 years).

245 At a median follow-up of 68 months (interquartile range, 58-74 months), 157 and 156 DFS even

246 .7 to 59.6] to primary melanomas (MFI, 68.8; interquartile range, 58.4 to 77.0) and metastatic melano

247 n that of invasive adenocarcinoma (939 days [interquartile range, 588-1563 days] vs 678 days [interqu

248 antibiotic duration in the CRP group was 7 (interquartile range, 6-10; range, 5-28) days; 34 of the

249 st infections appeared at a median age of 8 (interquartile range, 6.0-11.7) months.

250 s and their children (median age, 8.2 years; interquartile range, 6.6-9.1) from the European Human Ea

251 ients (48.7% female, median age of 75 years [interquartile range, 64- 83]).

252 lume surgeons (median range, 111 procedures; interquartile range, 69-172 vs 77 procedures, interquart

253 erquartile range, 5.2-9.1) versus 9.4 years (interquartile range, 7.6-12.8) for failures (P < .001).

254 arted at the lowest oxygenation index (13.0; interquartile range, 7.6-22.0) and HFOV at the highest (

255 study fluid administered on day 1: 1250 mL (interquartile range, 750-2000 mL) in the HES group and 1

256 , 750-2000 mL) in the HES group and 1500 mL (interquartile range, 750-2150 mL) in the saline group (m

257 o 77.0) and metastatic melanomas (MFI, 87.5; interquartile range, 77.1 to 114.5) (P < 0.001).

258 ian age of 84 years (age range, 51-98 years; interquartile range, 79-88 years) and median follow-up o

259 ore the age of 40 months (median, 16 months; interquartile range, 9-29 months).

260 system was in the closed-loop mode was 93% (interquartile range, 91 to 95).

261 Variability should be described by S.D. or interquartile range, and precision should be described b

262 Median, interquartile range, and range were calculated for each

263 P = 0.03) and more publications [median 70 (interquartile range, IQR 55-100) vs 40 (IQR 22-67), P =

264 e epithelium was 1.47 +/- 1.17 (median: 1.5; interquartile range: 0.3-2.4).

265 : 1.05-1.35) and 0.76 +/- 0.49 (median: 0.7; interquartile range: 0.4-1.15) vs. 3.63 +/- 0.29 (median

266 ients with a median PSA level of 0.97 ng/mL (interquartile range: 0.41-2.46 ng/mL) were included.

267 During a median follow-up of 2.42 years (interquartile range: 1.04 to 4.29 years), 167 patients d

268 : 3.25-3.55) vs. 1.23 +/- 0.23 (median: 1.2; interquartile range: 1.05-1.35) and 0.76 +/- 0.49 (media

269 patients followed for a median of 2.7 years (interquartile range: 1.3 to 4.4 years), the cumulative i

270 During a median follow-up of 3.6 years (interquartile range: 1.3 to 5.3 years), 830 (16.4%) pati

271 en CT acquisition and report was 25 minutes (interquartile range: 13-49 minutes).

272 nilateral PGA exposure time was 31.7 months (interquartile range: 18.8-44.3 months).

273 13.2% during a median follow-up of 632 days (interquartile range: 187 to 1,126 days).

274 Over a median follow-up of 6.2 years (interquartile range: 2.7 to 16.5 years), 17 patients exp

275 The median age was 24 (interquartile range: 20-30) years.

276 ose with P. knowlesi, the median age was 35 (interquartile range: 24-47) years, and 85% were male.

277 During a median follow-up of 56 (interquartile range: 28 to 106 months) months, 334 (51%)

278 tic AKI-RRT patients, median age 47.6 years (interquartile range: 29.0-64.3) and 76.4% male, were ide

279 n and adults was 3.37 +/- 0.34 (median: 3.4; interquartile range: 3.25-3.55) vs. 1.23 +/- 0.23 (media

280 e: 0.4-1.15) vs. 3.63 +/- 0.29 (median: 3.7; interquartile range: 3.45-3.8), respectively.

281 ation rate (eGFR) was 43.7 ml/min/1.73 m(2) (interquartile range: 30.9 to 60.1 ml/min/1.73 m(2)), and

282 nfatal myocardial infarction over 42 months (interquartile range: 31 to 49 months).

283 ts (62.3%) within a median time of 103 days (interquartile range: 32 to 392 days).

284 3 (34%) by last follow-up (median 63 months; interquartile range: 39 to 87).

285 Median follow-up was 8.0 years (interquartile range: 4.0 to 13.3 years) and 86 (30.2%) p

286 s after importation would be reduced by 76% (interquartile range: 73-77%).

287 patients, the median MELD-XI score was 10.2 (interquartile range: 9.4 to 13.3); 53 (8%) died and 3 (0

288 ndex scores than their actual donor (median [interquartile range] 31.5 [12.3-47]; P < 0.001 and 26 (-

289 Overall, 2,062 patients (62% men, median [interquartile range] age 59 yr [48-67 yr]) were included

290 and at least 1 postbaseline survey (median [interquartile range] age, 64 [59-70] years; 1529 of 1993

291 We studied 347 patients (median [interquartile range] age: 64 yr [53-71 yr] and Acute Phy

292 graphy was delayed by several hours (median [interquartile range] delay = 239 minutes [134-471 min] [

293 patients with HFrEF (65+/-11 years, median [interquartile range] left ventricular ejection fraction

294 Time to electroencephalography (median [interquartile range]) was 5 minutes (4-10 min) with rapi

295 ed endotracheal intubation (n = 12) (median [interquartile range], 11 [8-15] cm H(2)O vs. 31.5 [30-36

296 live and out of hospital at 30 days (median [interquartile range], 19 [0- 24] d in both groups; adjus

297 ing follow-up (mean [SD], 358 [384]; median [interquartile range], 232 [10-599] days), BE TAVR was as

298 d 950 (93%) completed the follow-up (median [interquartile range], 5.6 [3.6-7.3] years); 117 experien

299 ery was significantly lower for EVR (median [interquartile range]: $25 924 [$22 280-$32 556] EVR vers

300 f symptom-onset-to-baseline-CT (hr) (median [interquartile range]: 3 [4] vs 5 [5]; p = 0.468) and fol